Published August 24, 2023
0 views Journal article Open Access Open Access

Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer.

Creators

  • 1. Italian Association of Clinical Diabetologists, 00192 Rome, Italy.
  • 2. Endocrinology and Metabolic Diseases Unit, AO SS Antonio e Biagio e Cesare Arrigo of Alessandria, 15121 Alessandria, Italy.
  • 3. Diabetology and Nutrition Unit, Department of Medical Specialities, ASL Roma 1, S. Spirito Hospital, 00193 Rome, Italy.
  • 4. Internal Medicine Department, Ospedale dei Castelli, Asl Roma 6, 00040 Ariccia, Italy.
  • 5. Diabetology, Endocrinology and Metabolic Diseases Service, ASL-Sulcis, 09016 Iglesias, Italy.
  • 6. Endocrinology Unit, Department of Clinical & Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy.
  • 7. Sapienza University of Rome
  • 8. Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, 70121 Bari, Italy.
  • 9. University of Bari
  • 10. Section of Endocrinology, Geriatrics and Internal Medicine, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.
  • 11. Department of Precision and Regenerative Medicine and Ionian Area, Section of Pharmacology, University of Bari Aldo Moro, 70121 Bari, Italy.
  • 12. Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
  • 13. University of Pisa
  • 14. Department of Oncology, Istituto Oncologico del Mediterraneo, Viagrande, 95029 Catania, Italy.
  • 15. Medical Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.
  • 16. Scientific Institute for Research, Hospitalization and Healthcare
  • 17. Interdisciplinary Department of Medicine, University of Bari Aldo Moro, 70121 Bari, Italy.
  • 18. Oncologia Medica, IRCCS Ospedale Don Calabria-Sacro Cuore di Negrar, 37024 Verona, Italy.
  • 19. Medical Oncology Unit, Department of Human Pathology "G. Barresi", University of Messina, 98122 Messina, Italy.
  • 20. Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, 90133 Palermo, Italy.
  • 21. Diabetology, Careggi University Hospital, University of Florence, 50134 Florence, Italy.
  • 22. University of Florence
  • 23. Department of Clinical and Experimental Medicine, Endocrinology Section, University of Catania, 95124 Catania, Italy.
  • 24. Medical Oncology Division, Breast Unit, Senatore Antonio Perrino Hospital, ASL Brindisi, 72100 Brindisi, Italy.
  • 25. Endocrinology, Diabetology and Andrology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, 80138 Naples, Italy.
  • 26. UNESCO Chair, Education for Health and Sustainable Development, Federico II University, 80131 Naples, Italy.
  • 27. Department of Medicine, Section of Diabetes and Metabolic Diseases, University of Padova, 35122 Padova, Italy.
  • 28. University of Padua
  • 29. Diabetes Unit, Livorno Hospital, 57100 Livorno, Italy.

Description

There is increasing evidence of the role of endocrine disruptors (EDs) derived from commonly employed compounds for manufacturing and processing in altering hormonal signaling and function. Due to their prolonged half-life and persistence, EDs can usually be found not only in industrial products but also in households and in the environment, creating the premises for long-lasting exposure. Polybrominated diphenyl ethers (PBDEs) are common EDs used in industrial products such as flame retardants, and recent studies are increasingly showing that they may interfere with both metabolic and oncogenic pathways. In this article, a multidisciplinary panel of experts of the Italian Association of Medical Diabetologists (AMD), the Italian Society of Diabetology (SID), the Italian Association of Medical Oncology (AIOM), the Italian Society of Endocrinology (SIE) and the Italian Society of Pharmacology (SIF) provides a review on the potential role of PBDEs in human health and disease, exploring both molecular and clinical aspects and focusing on metabolic and oncogenic pathways.
Enabled by The Lens

Open Access

Publisher Website Access full text